With extensive experience in venture capital, the fund manager has actively engaged in the technology and healthcare sectors, primarily focusing on early-stage investments. Their strategic, data-driven approach has facilitated over 30 successful deals, leading to notable exits such as a major tech unicorn and a transformative biotech company. Operating predominantly in North America and Europe, they emphasize a thematic investment style that prioritizes innovative solutions in high-growth markets. Their operational background further enhances their ability to support portfolio companies in scaling effectively.